Search Results - "Cleland, J.G.F"

The year in cardiology : heart failure The year in cardiology 2019 by Lyon, Alexander R., McMurray, John J.V., McDonagh, Theresa, Cleland, John G.F.

“…The past year has brought many new concepts and an abundance of new data on the nature, management, and outcome of heart failure. The pace of change is…”
Get full text

New ways to visualize and combat congestion in heart failure by Pellicori, P, Cleland, J G F

Get full text

The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points by Cleland, J.G.F., Daubert, J.C., Erdmann, E., Freemantle, N., Gras, D., Kappenberger, L., Klein, W., Tavazzi, L.

“…Background: Cardiac resynchronisation is a promising new intervention for patients with heart failure, left ventricular systolic dysfunction and ventricular…”
Get full text

Derivation and validation of a simple clinical risk-model in heart failure based on 6 minute walk test performance and NT-proBNP status – Do we need specificity for sex and beta-blockers? by Frankenstein, L, Goode, K, Ingle, L, Remppis, A, Schellberg, D, Nelles, M, Katus, H.A, Clark, A.L, Cleland, J.G.F, Zugck, C

“…Abstract Background It is unclear whether risk prediction strategies in chronic heart failure (CHF) need to be specific for sex or beta-blockers. We examined…”
Get full text

The Selective Cardiac Myosin Activator, CK-1827452, Increases Systolic Function in Heart Failure by Cleland, J.G.F, Malik, F.I

Get full text

A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE by Savarese, G., Costanzo, P., Cleland, J.G.F., Vassallo, E., Ruggiero, D., Rosano, G., Perrone-Filardi, P.

“…Translation articles: G. Savarese, P. Costanzo, J.G.F. Cleland, E. Vassallo, D. Ruggiero, G. Rosano, P. Perrone-Filardi «A Meta-Analysis Reporting Effects of…”
Get full text

The Selective Cardiac Myosin Activator, CK-1827452, Increases Systolic Function in a Concentration-Dependent Manner in Patients with Stable Heart Failure (10/8/08) by Cleland, J.G.F, Nifontov, E.M, McMurray, J.J.V, Senior, R, Lang, C.C, Clarke, C.P, Francis, D, Greenberg, B, Mayet, J, Monaghan, M, Neyses, L, Tsyrlin, V.A, Goldman, J.H, Teerlink, J.R, Brand, G, Lee, J.H, Saikali, K.G, Wolff, A.A, Malik, F.I

Get full text

Is Telemonitoring the Answer for Chronic Heart Failure Patients Distal to Specialist Services? by Clark, R.A, Inglis, S.C, McAlister, F.A, Cleland, J.G.F, Stewart, S

Get full text

Natural history and prognostic significance of anaemia and iron deficiency in ambulatory patients with heart failure by Graham, F.J, Masini, G, Pellicori, P, Cleland, J.G.F, Kazmi, S, Clark, A.L

“…Abstract Background Anaemia and iron deficiency (ID) are both common and associated with adverse outcomes in patients with heart failure (HF). However, the…”
Get full text

Heart rate as a marker of relapse during withdrawal of heart failure therapy in patients with recovered dilated cardiomyopathy: an analysis from TRED-HF by Halliday, B, Vazir, A, Owen, R, Gregson, J, Wassall, R, Lota, A.S, Cowie, M.R, Cleland, J.G.F, Prasad, S.K

“…Abstract Introduction In TRED-HF, 40% of patients with recovered dilated cardiomyopathy (DCM) relapsed in the short-term during phased withdrawal of drug…”
Get full text

Controlling persistent atrial fibrillation by Shelton, R.J., Kaye, G.C., Cleland, J.G.F.

Get full text

Diuretic Treatment in Patients with Heart Failure: Current Evidence and Future Directions—Part II: Combination Therapy by J J, Cuthbert, J G F, Cleland, A L, Clark

“…Purpose of Review Fluid retention or congestion is a major cause of symptoms, poor quality of life, and adverse outcome in patients with heart failure (HF)…”
Get full text

Ischemic heart disease is more prevalent in low-income-countries and more often undertreated: data from report-hf by Tromp, J, Bamadhaj, S, Cleland, J.G.F, Angermann, C.E, Dahlstrom, U, Ertl, G, Hassanein, M, Perrone, S.V, Ghadanfar, M, Schweizer, A, Obergfell, A, Collins, S.P, Filipatos, G.F, Lam, C.S.P, Dickstein, K

“…Abstract Background The pathogenic role of ischemic heart disease (IHD) in heart failure is well known. However, little is known about the global differences…”
Get full text

Dynamic risk stratification using serial measurements of plasma concentrations of natriuretic peptides in patients with heart failure by Zhang, J., Pellicori, P., Pan, D., Dierckx, R., Clark, A.L., Cleland, J.G.F.

“…Prognostic models for patients with chronic heart failure are generally based on a single assessment but treatment is often given with the intention of…”
Get full text

Effects of increased inspired oxygen concentrations on exercise performance in chronic heart failure by Moore, D P, Weston, A R, Hughes, J M, Oakley, C M, Cleland, J G

“…Exercise capacity in patients with stable heart failure may be influenced by prolonged drug treatment or exercise training, but acute interventions are…”
Get more information

The heart failure epidemic: exactly how big is it? by Cleland, J.G.F., Khand, A., Clark, A.

Get full text

Cardiac resynchronization therapy with or without an implantable defibrillator: only indicated when everything else has failed? by Ghosh, J, Kaye, Gerry, Cleland, J G F

“…Cardiac resynchronization therapy (CRT) is potentially an important new treatment for patients with heart failure due to left ventricular systolic dysfunction…”
Get more information

The Warfarin/Aspirin study in heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure by Cleland, J.G.F, Findlay, I, Jafri, S, Sutton, G, Falk, R, Bulpitt, C, Prentice, C, Ford, I, Trainer, Adele, Poole-Wilson, P.A

“…Heart failure is commonly associated with vascular disease and a high rate of athero-thrombotic events, but the risks and benefits of antithrombotic therapy…”
Get full text

Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance. Are they interchangeable? by Bellenger, N.G, Burgess, M.I, Ray, S.G, Lahiri, A, Coats, A.J.S, Cleland, J.G.F, Pennell, D.J

“…Aims To prospectively compare the agreement of left ventricular volumes and ejection fraction by M-mode echocardiography (echo), 2D echo, radionuclide…”
Get full text

Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety by Gras, D., Böcker, D., Lunati, M., Wellens, H.J.J., Calvert, M., Freemantle, N., Gervais, R., Kappenberger, L., Tavazzi, L., Erdmann, E., Cleland, J.G.F., Daubert, J.-C.

“…Aims To assess procedural characteristics and adjudicated procedure-related (≤30 days) major adverse events among patients who underwent cardiac…”
Get full text